Pulmonary Therapy is an international, open access, peer-reviewed (single-blind), and rapid publication journal. The scope of the journal is broad, covering the use of pulmonary therapies, devices, and surgical techniques. The key features of the journal are: Rapid publication: The journal aims for a 2-week peer review, 3-4 weeks from acceptance to online. Open access: All articles published open access (CC-BY-NC). Inclusivity: All scientifically sound research considered be it positive, confirmatory or negative data. Research is considered from clinical phase, real-world and health economics outcomes studies. Submissions are welcomed whether they relate to an international or a country-specific audience. Personal service: The journal’s team will re-format articles and upload submissions on behalf of authors, if necessary. Digital Features and Plain Language Summaries: These peer-reviewed features are welcomed to help enhance the educational value of a manuscript (for more information see “Author Information – Guidelines for digital features and plain language summaries” under “Submission guidelines”). Publication fees: Upon acceptance of an article, authors will be required to pay the mandatory Rapid Service Fee of €5500/ $6850/ £4700. The journal will consider fee discounts and waivers for developing countries and this is decided on a case by case basis. If you would like to request a discount or waiver please do so either ahead of submission or at the very start of the submission process. Requests made after this stage will not be considered. Contact: For more information about the journal, including pre-submission enquiries, please contact Charley Lai at charley.lai@springer.com. Presents research on the use of pulmonary therapies, devices, and surgical techniques Rapid publication and personal point of contact throughout Maximum visibility with open access